NCT06191614View on ClinicalTrials.gov

DEXINEURO® Tab on Blood Glucose Reduction in Patients With Type 2 Diabetes Accompanied by Diabetic Peripheral Neuropathy

CompletedOBSERVATIONAL

Enrollment

528

Participants

Timeline

Start Date

May 19, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions

Diabetic Peripheral Neuropathy

Trial Locations (1)

Unknown

Keimyung University Dongsan Hospital, Daegu

All Listed Sponsors

lead

Hanlim Pharm. Co., Ltd.

INDUSTRY